Navigation Links
Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Date:9/17/2007

ous academic clinical research and results of use of the neo-bladder at Children's Hospital Boston were described in an article published in The Lancet on April 15, 2006.

The neo-bladder constructs for patients in both Phase 2 clinical trials are being developed at Tengion's state-of-the-art manufacturing facility using cells taken from a small biopsy of each patient's bladder. Each neo-bladder construct consists of a biodegradable scaffold seeded with cells cultured by Tengion scientists from the patient's own (i.e., autologous) healthy cells. A surgeon implants the neo-bladder construct in the patient's body, where it is designed to harness the body's inherent regenerative capabilities resulting in a regenerated bladder with improved functionality. The primary efficacy endpoint of the trial is urodynamic function of the neo-bladder at one year post-implantation. Data on the safety profile of the product will continue to be collected after the one-year endpoint measurement date. The trial is expected to complete enrollment over the next few months.

If the implanted neo-bladder constructs prove safe and effective, they have the potential to reduce the risks and complications associated with present means of treating failing bladders in adults with spinal cord injuries. The most common surgical procedure currently used to treat patients with failing bladders is known as enterocystoplasty, a procedure that was developed more than 100 years ago that uses the patient's own bowel tissue to augment the failing bladder. This procedure is associated with substantial and well-described side effects and risks.

"Bladder failure patients have not seen new treatment options in decades, and Tengion's technology has the potential to be a compelling advance," said Roger R. Dmochowski, M.D., professor with Vanderbilt University's Department of Urology. "We have been encouraged by results to date and look forward to the continued evaluation of the neo-bladder constr
'/>"/>

SOURCE Tengion, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
5. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
6. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
7. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
8. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
9. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
10. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
11. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... YORK , Aug. 20, 2014 ... is available in its catalogue: Global ... http://www.reportlinker.com/p01375204/Global-Coatings-for-Medical-Devices-Industry.html This report ... Devices in US$ Million by the following Product ... Nanotechnology Coatings. The report provides separate comprehensive analytics ...
(Date:8/20/2014)... PHOENIX , Aug. 20, 2014 ... cutting-edge next-generation sequencing and proteomic diagnostics and biomarker ... a collaboration with TESARO, Inc.  Paradigm will use ... samples from clinical trials to better predict which ... TSR-011.  This may lead to more successful clinical trial ...
(Date:8/20/2014)... ApolloDx™ today announced it will unveil and ... event at the company,s office in Salt ... The event, which will start at 10:00 a.m., will ... .    "We believe our mobile diagnostic ... , Co-Founder and Managing Partner of ApolloDx. In addition ...
Breaking Medicine Technology:Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... company with operations in China and the United States, ... the third quarter of 2011 after the New York ... will be Friday morning, November 11, 2011 Shanghai time). ...
... 2011 Philips Respironics, a unit of Royal Philips ... treating and managing the full spectrum of sleep and ... kind at Medtrade 2011. The largest national educational and ... (HME) industry kicks off this week at Georgia World ...
Cached Medicine Technology:WuXi PharmaTech Schedules Third-Quarter 2011 Earnings Release 2Philips Respironics Unveils "Pathway to Better Outcomes" for Home Health Care 2Philips Respironics Unveils "Pathway to Better Outcomes" for Home Health Care 3Philips Respironics Unveils "Pathway to Better Outcomes" for Home Health Care 4
(Date:8/20/2014)... iFitDress.com, the well-known wedding dress manufacturer and retailer, ... evening gowns . All items in the fresh collection ... $100. , iFitDress.com is among the hardest working ... best to help clients worldwide to keep pace with ... and professional. According to its development manager, all its ...
(Date:8/20/2014)... August 20, 2014 The ... (IBCCES) , an organization recognizing professionals dedicated to ... has announced that with a certificate in ... people on the Autism Spectrum have a way ... quality care. This, in turn, say IBCCES representatives, ...
(Date:8/20/2014)... 20, 2014 Ticket Down is a ... in NYC. In just a week, the U.S. Open Tennis ... Center. The event was originally founded in 1881 and features grass ... was forced to withdrawal from the event because of a wrist ... and will return to New York City with hopes of winning ...
(Date:8/20/2014)... Line: A study in Australia examined patient and ... (a marker of tumor cell growth) in an ... cancer in patients. , Author: ... Victoria, Australia, and colleagues. , Background: The ... cell division) has been connected with prognosis and ...
(Date:8/20/2014)... deploy Ebola vaccines is now, Free content, The ... to a commentary being published early online today in ... authors from Yale School of Public Health write that ... current Ebola outbreak represent a public health crisis that ... Ebola vaccines have been developed in the last decade, ...
Breaking Medicine News(10 mins):Health News:iFitDress.com Releases a New Range of Cheap Evening Gowns 2Health News:National Autism Certificate Credentialing Board IBCCES Increases Job Placement Opportunities for Those Dedicated to Working Within the Autism Spectrum 2Health News:National Autism Certificate Credentialing Board IBCCES Increases Job Placement Opportunities for Those Dedicated to Working Within the Autism Spectrum 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:News from Annals of Internal Medicine 2
... Taking serious note of doctors using advertisements to lure ... Monday asked the state's medical council to take steps ... education and research minister Tikshan Sood said here that ... but also a violation of the Medical Council Act. ...
... say that they have developed a faster, less expensive ... stretches of DNA. The development of the new technique ... mutant genes, but also from mutations of other DNA ... occur as a consequence of deleting non-gene DNA sequences, ...
... that playing with candy cigarettes may favorably set the ... . , The study, reported in the ... nationally representative sample of 25,887 US adults, the percentages ... current and former smokers vs. 22% in never smokers, ...
... discovery by Fox Chase Cancer Center researchers helps explain ... viral diseases. The research shows lymph nodes are not ... also are the sites where a major fight against ... ,After becoming sick from many viruses, the body becomes ...
... dogs are at risk of suffering broken bones, torn ... owner and pet, there are veterinarians who can ... feet. James Roush, an orthopedic surgeon at the Veterinary ... such veterinarian. ,Roush frequently performs orthopedic surgeries ...
... a team of Emory University scientists have found a ... mutations recently identified in Parkinson disease development. These new findings ... provide a target for drug therapies to treat the disease. ... central nervous system resulting from the loss of neurons in ...
Cached Medicine News:Health News:Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA 2Health News:The Danger in Candy Cigarettes 2Health News:Memory T Cells Protect the Body from Viruses 2Health News:Some Common Human Injuries Also Common in Dogs 2Health News:Some Common Human Injuries Also Common in Dogs 3Health News:Parkinsons Disease Protein Pathway Identified 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: